Cargando…
Thrombolytic Therapy in the Oldest Old: Successful Alteplase Administration in a 105-Year-Old Female With Ischemic Stroke
The elderly have a higher incidence of ischemic stroke along with higher mortality and morbidity compared to their younger counterparts. However, though studies have included people >85 or 90 years of age, there haven’t been reports of many individuals above 100 years of age. Among the oldest old...
Autores principales: | Bhandari, Sambhawana, Baral, Maun R, Espana Schmidt, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653926/ https://www.ncbi.nlm.nih.gov/pubmed/34909307 http://dx.doi.org/10.7759/cureus.19346 |
Ejemplares similares
-
Intravenous Thrombolytic Treatment in the Oldest Old
por: García-Caldentey, Juan, et al.
Publicado: (2012) -
Ipsilateral Orolingual Angioedema Following Alteplase Administration for the Treatment of Suspected Acute Ischemic Stroke
por: Tolu-Akinnawo, Oluwaremilekun, et al.
Publicado: (2023) -
Iatrogenic Pneumocephalus Resolved by Oxygen Therapy
por: Bhandari, Sambhawana, et al.
Publicado: (2021) -
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022) -
Possible Aripiprazole-Induced Hypothermia: An “Icy” Side Effect?
por: Bhandari, Sambhawana, et al.
Publicado: (2021)